Related Experiment Videos
Genetic abnormalities in hereditary hemorrhagic telangiectasia
1Department of Genetics, Duke University Medical Center, Durham, NC 27710, USA.
Current Opinion in Hematology
|October 17, 1998
Summary
Hereditary hemorrhagic telangiectasia (HHT) is an inherited vascular disorder caused by mutations in endoglin or ALK-1 genes. Haploinsufficiency of these genes leads to abnormal blood vessel formation and bleeding, with mouse models proposed for further study.
Area of Science:
- Genetics
- Vascular Biology
- Pathophysiology
Background:
- Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber disease, is an autosomal dominant disorder.
- It is characterized by localized angiodysplasia, specifically direct arteriovenous connections lacking a capillary bed.
- Despite its vascular nature, HHT is sometimes misidentified as a hemostatic disorder due to associated bleeding.
Purpose of the Study:
- To investigate the genetic basis of HHT.
- To understand the role of endoglin and ALK-1 genes in vascular development.
- To propose a pathogenetic model for HHT development.
Main Methods:
- Analysis of germline mutations in endoglin and ALK-1 genes.
- Biochemical studies on endoglin and TGF-beta signaling.
- Proposal of a haploinsufficiency model for HHT pathogenesis.
Main Results:
- Germline mutations in endoglin or ALK-1 genes are identified as causes of HHT.
- These genes encode proteins in the transforming growth factor (TGF)-beta receptor family, expressed on endothelial cells.
- Most mutations result in null alleles, leading to reduced gene or protein levels.
Conclusions:
- A haploinsufficiency model is proposed, where inheriting a mutation predisposes individuals to HHT.
- The precise factors initiating lesion formation remain unknown.
- Development of mouse models with disrupted endoglin or ALK-1 genes is suggested for further research into HHT pathogenesis.